Viking Therapeutics Inc

Viking Therapeutics Inc (VKTX) Price Prediction & Forecast

$32.160

-1.614 (-5.02%)At close

Price Predictions

1-Day Price Prediction
+1.75%
1-Week Prediction
+2.31%
1-Month Prediction
2026 Prediction
2030 Prediction

Open in app to unlock longer-horizon forecasts.

Loading chart…

VKTX Prediction & Forecast by Similar Chart Analysis

Alphio's VKTX stock price prediction model matches the current Viking Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $32.72 (+1.75%). The 1-week path is $32.90 (+2.31%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy Viking Therapeutics Inc Stock?

Viking Therapeutics Inc is currently not a strong buy due to its current price of $32.16 and an RSI of 32.658, indicating it is oversold. The company is facing significant net losses, with a projected net income loss of $158 million in Q1 2026, which raises concerns about its financial health. However, the positive news regarding its cash position and upcoming clinical trials could provide future upside.

VKTX stock price ended at $32.16 on Friday, after losing -5.02%

Viking Therapeutics Inc (VKTX) last closed at $32.16, losing -5.02%. These facts feed the 1-day and 1-week VKTX price prediction above.

Analyst Consensus

Viking Therapeutics Inc (VKTX): 3 buy, 0 hold, 0 sell. Outlook: Strong Buy.

Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.

Strong sellSellNeutralBuyStrong buy
Buy
Sell
0
Buy
3

Forecast Drivers

Viking Therapeutics Inc (VKTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

Similar Chart Patterns

Stocks whose recent price path most closely matches VKTX, ranked by similarity.

Seasonality analysis for VKTX

Historically the probability of a positive August return for VKTX is 39.68%. July offers the highest probability of a positive month at 56.06%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

10-year price projections for VKTX

MonthMin PriceAvg PriceMax PricePotential ROI
Aug 2026$29.11$31.69$34.90-1.47%
Sep 2026$32.35$38.65$43.77+20.19%
Oct 2026$34.27$38.65$45.92+20.19%
Nov 2026$28.76$35.24$38.15+9.58%
Dec 2026$28.47$28.57$29.25-11.17%

In 2026, Viking Therapeutics Inc (VKTX) is projected to range from $28.47 to $45.92.

Viking Therapeutics Inc 2026 monthly forecast

Aug 2026 VKTX forecast
Potential ROI: -1.47%

In Aug 2026, Viking Therapeutics Inc is projected to average $31.69, with a low of $29.11 and high of $34.90.

Sep 2026 VKTX forecast
Potential ROI: 20.19%

In Sep 2026, Viking Therapeutics Inc is projected to average $38.65, with a low of $32.35 and high of $43.77.

Oct 2026 VKTX forecast
Potential ROI: 20.19%

In Oct 2026, Viking Therapeutics Inc is projected to average $38.65, with a low of $34.27 and high of $45.92.

Nov 2026 VKTX forecast
Potential ROI: 9.58%

In Nov 2026, Viking Therapeutics Inc is projected to average $35.24, with a low of $28.76 and high of $38.15.

Dec 2026 VKTX forecast
Potential ROI: -11.17%

In Dec 2026, Viking Therapeutics Inc is projected to average $28.57, with a low of $28.47 and high of $29.25.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started